Copyright © 2002 by the European Society of Cardiology.
Septal myotomy–myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes
Department of Cardiological Sciences, St George's Hospital Medical School, London, U.K.
revised April 29, 2002; accepted May 1, 2002
Abstract
Aims Surgical myectomy has been successfully used to treat patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM). More recently, alcohol septal ablation has been advocated as a less invasive, but equally effective alternative therapy. The aim of this non-randomized cohort study was to compare subjective and objective outcomes in patients undergoing these therapies.
Methods Forty-four patients (25 male; age 41±15 years) with symptomatic drug-refractory obstructive HCM were studied. Twenty-four patients underwent surgical myectomy and 20 alcohol septal ablation. All patients underwent clinical evaluation, echocardiography and upright maximal cardiopulmonary exercise testing using a cycle ergometer before and following their intervention.
Results Peak gradient was reduced to a similar extent by both modalities (myectomy: 83±23 to 15±10mmHg (P<0·000001); ablation: 91±18 to 22±14mmHg (P<0·000002);P =0·48 for myectomy vs ablation) and led to similar improvements in NYHA class (myectomy: 2·4±0·6 to 1·5±0·7 (P<0·00001); ablation: 2·3±0·5 to 1·7±0·8 (P<0·0001);P=0·3 for myectomy vs ablation). Myectomy resulted in a greater improvement in peak oxygen consumption (myectomy: 16·4±5·8 to 23·1±7·1ml.kg–1 min–1 (P<0·00002); ablation: 16·2±5·2 to 19·3±6·1ml.kg–1 min–1 (P<0·05);P <0·05 for myectomy vs ablation) and work rate achieved (myectomy: 130±57 to 161±60 watts (P<0·04); ablation: 121±53 to 137±51 watts (P=0·11);P <0·05 for myectomy vs ablation).
Conclusion Surgical myectomy and alcohol septal ablation are equally effective at reducing obstruction and subjective exercise limitation in appropriately selected patients. However, the superior effect of surgical myectomy on exercise test parameters suggests that surgery remains the gold standard against which new treatment modalities should be compared. Copyright 2002 The European Society of Cardiology. Published by Elsevier Science Ltd. All rights reserved.
Key Words: Hypertrophic cardiomyopathy, obstruction, myectomy, alcohol septal ablation, peak oxygen consumption
f1 Correspondence: Dr P. M. Elliott, Department of Cardiological Sciences, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, U.K.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S R Ommen, P M Shah, and A J Tajik Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future Heart, October 1, 2008; 94(10): 1276 - 1281. [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Jacques, N. Briceno, A. E. Messer, C. E. Gallon, S. Jalilzadeh, E. Garcia, G. Kikonda-Kanda, J. Goddard, S. E. Harding, H. Watkins, et al. The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy Cardiovasc Res, August 1, 2008; 79(3): 481 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sorajja, U. Valeti, R. A. Nishimura, S. R. Ommen, C. S. Rihal, B. J. Gersh, D. O. Hodge, H. V. Schaff, and D. R. Holmes Jr Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy Circulation, July 8, 2008; 118(2): 131 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Durand, E. Mousseaux, P. Coste, R. Pilliere, O. Dubourg, L. Trinquart, G. Chatellier, A. Hagege, M. Desnos, and A. Lafont Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up Eur. Heart J., February 1, 2008; 29(3): 348 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Fifer and G. J. Vlahakes Management of Symptoms in Hypertrophic Cardiomyopathy Circulation, January 22, 2008; 117(3): 429 - 439. [Full Text] [PDF]
|
|
|
|
|
|
B. J. Maron Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy Circulation, July 10, 2007; 116(2): 196 - 206. [Full Text] [PDF]
|
|
|
|
|
|
M. A. Fifer Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy Circulation, July 10, 2007; 116(2): 207 - 216. [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Heldman, K. C. Wu, T. P. Abraham, and D. E. Cameron Myectomy or Alcohol Septal Ablation: Surgery and Percutaneous Intervention Go Another Round J. Am. Coll. Cardiol., January 23, 2007; 49(3): 358 - 360. [Full Text] [PDF]
|
|
|
|
|
|
P. M. Elliott, J. R. Gimeno, M. T. Tome, J. Shah, D. Ward, R. Thaman, J. Mogensen, and W. J. McKenna Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy Eur. Heart J., August 2, 2006; 27(16): 1933 - 1941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Ommen, B. J. Maron, I. Olivotto, M. S. Maron, F. Cecchi, S. Betocchi, B. J. Gersh, M. J. Ackerman, R. B. McCully, J. A. Dearani, et al. Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy J. Am. Coll. Cardiol., August 2, 2005; 46(3): 470 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Yacoub Surgical Versus Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: The Pendulum Swings Circulation, July 26, 2005; 112(4): 450 - 452. [Full Text] [PDF]
|
|
|
|
|
|
C. van der Lee, F. J. ten Cate, M. L. Geleijnse, M. J. Kofflard, C. Pedone, L. A. van Herwerden, E. Biagini, W. B. Vletter, and P. W. Serruys Percutaneous Versus Surgical Treatment for Patients With Hypertrophic Obstructive Cardiomyopathy and Enlarged Anterior Mitral Valve Leaflets Circulation, July 26, 2005; 112(4): 482 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Woo, W. G. Williams, R. Choi, E. D. Wigle, E. Rozenblyum, K. Fedwick, S. Siu, A. Ralph-Edwards, and H. Rakowski Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy Circulation, April 26, 2005; 111(16): 2033 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Kimmelstiel and B. J. Maron Role of Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy Circulation, February 3, 2004; 109(4): 452 - 456. [Full Text] [PDF]
|
|